Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency

Clinical trial NCT00355264 · COMPLETED

Trial details

NCT number: NCT00355264
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetrahydrobiopterin Deficiencies Hyperphenylalaninemia, Non-Phenylketonuric

Start date: 2006-08-01
Primary completion: 2009-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.